Clinical Trials Browser

OTHER × Melanoma × Molecular Targeted Therapy × Clear all

NCT02094872 2020-01-02

Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

Phase 2 Completed

49 enrolled 8 charts

Melanoma